UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033739
Receipt number R000038479
Scientific Title Randomized double-blind comparative study on the effect of bifidobacterial on the low dose oral immunotherapy for egg allergy children.
Date of disclosure of the study information 2018/08/15
Last modified on 2022/08/23 12:55:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized double-blind comparative study on the effect of bifidobacterial on the low dose oral immunotherapy for egg allergy children.

Acronym

Study on the effect of bifidobacterial on the low dose oral immunotherapy for egg allergy children.

Scientific Title

Randomized double-blind comparative study on the effect of bifidobacterial on the low dose oral immunotherapy for egg allergy children.

Scientific Title:Acronym

Study on the effect of bifidobacterial on the low dose oral immunotherapy for egg allergy children.

Region

Japan


Condition

Condition

Hen's egg allergy

Classification by specialty

Clinical immunology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Low-dose oral immunotherapy is performed to infant with egg allergy.
These participants are randomly divided into bifidobacteria group and placebo(dextrin) group. The bifidobacterial group daily receive bifidobacteria, while the placebo group daily receive dextrin during treatment.
In this study, we investigated the efficacy of bifidobacteria at low-dose OIT.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate of 1/8 hen's egg tolerance at 32 weeks after intervention started

Key secondary outcomes

The rate of 1/32 hen's egg desensitization at 32 weeks after intervention started.
Objective indicater(blood:change in eosinophil count,total IgE,antien specific IgE(egg white,egg yolk,ovomucoid),antigen specific IgG4(egg white,ovomucoid),basophil stimulation test(OVM), faeces:intestinal flora, calprotectin,skin prick test)
Side reaction rate on oral immunotherapy,
Safety assessment(incidence of adverse events)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Bifidobacteria, twice a day, 42 weeks

Interventions/Control_2

Dextrin, twice a day, 42 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

2 years-old <=

Age-upper limit

5 years-old >=

Gender

Male and Female

Key inclusion criteria

a) Obvious hen's egg allergic patients
b) Patients who are 2 years or older and 5 years or younger at the start of the study
c) After receiving sufficient explanation for the participation of this study, patients who obtained document consent with the free will of the patient himself or substitute person with sufficient understanding

Key exclusion criteria

a) Of control poor atopic dermatitis or bronchial asthma
b) Cardiovascular, cranial nerve, Renal urology, Hepatobiliary, pancreatic, gastrointestinal, etc, which are serious or have diseases which may affect research
c) Implementing other immunotherapy
d) Other test responsibilities(shared) patients judged inappropriate by the doctor as subjects

Target sample size

68


Research contact person

Name of lead principal investigator

1st name Mayu
Middle name
Last name Maeda

Organization

Showa University

Division name

Department of pediatrics

Zip code

142-8666

Address

1-5-8 hatanodai, shinagawa-ku, Tokyo, Japan

TEL

0337848000

Email

mayu-shimi@med.showa-u.ac.jp


Public contact

Name of contact person

1st name Mayu
Middle name
Last name Maeda

Organization

Showa University

Division name

Department of Pediatrics

Zip code

142-8666

Address

1-5-8 hatanodai, shinagawa-ku, Tokyo, Japan

TEL

0337848000

Homepage URL


Email

mayu-shimi@med.showa-u.ac.jp


Sponsor or person

Institute

Showa University, Department of pediatrics

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

JPN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa University Hospital Institutional Review Board

Address

1-5-8 hatanodai, shinagawa-ku, Tokyo, Japan

Tel

0337848000

Email

mayu-shimi@med.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

48

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 01 Month 15 Day

Date of IRB

2018 Year 02 Month 05 Day

Anticipated trial start date

2018 Year 02 Month 15 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 08 Month 13 Day

Last modified on

2022 Year 08 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038479


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name